AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AngioDynamics (ANGO) Tops Q2 EPS by 3c, Revenues Beat; Offers FY21 EPS/Revenues
January 7, 2021 7:10 AM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $67.35 million.
Fiscal 2021 Second Quarter Highlights
Net sales of $72.8 million increased 4.0% compared to the prior-year quarterGross margin declined 410 basis points year over year to 55.2%GAAP loss per share of $0.11 and adjusted earnings per share of $0.01Cash and cash... More